Loading...
Twist Bioscience Corporation
TWST•NASDAQ
Healthcare
Medical - Diagnostics & Research
$35.99
$0.91(2.59%)
Twist Bioscience Corporation (TWST) Financial Performance & Income Statement Overview
Review Twist Bioscience Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
27.69%
↑ 27.69%
Operating Income Growth
-1.69%
↓ 1.69%
Net Income Growth
-2.01%
↓ 2.008%
Operating Cash Flow Growth
55.01%
↑ 55.01%
Operating Margin
-57.86%
↓ 57.86%
Gross Margin
46.70%
↑ 46.70%
Net Profit Margin
-54.98%
↓ 54.98%
ROE
-41.11%
↓ 41.11%
ROIC
-38.64%
↓ 38.64%
Twist Bioscience Corporation (TWST) Income Statement & Financial Overview
Review Twist Bioscience Corporation's (TWST) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $88.71M | $84.71M | $81.46M | $75.30M |
| Cost of Revenue | $45.87M | $46.48M | $46.19M | $44.42M |
| Gross Profit | $42.84M | $38.23M | $35.27M | $30.88M |
| Gross Profit Ratio | $0.48 | $0.45 | $0.43 | $0.41 |
| R&D Expenses | $21.31M | $21.13M | $22.47M | $24.15M |
| SG&A Expenses | $56.18M | $53.14M | $56.79M | $55.62M |
| Operating Expenses | $77.48M | $74.28M | $124.19M | $79.77M |
| Total Costs & Expenses | $123.36M | $120.75M | $170.39M | $124.19M |
| Interest Income | $3.24M | $3.62M | $3.66M | $3.94M |
| Interest Expense | $24000.00 | $29000.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $6.38M | $6.66M | $8.30M | $8.30M |
| EBITDA | -$25.09M | -$28.07M | -$77.08M | -$36.85M |
| EBITDA Ratio | -$0.28 | -$0.33 | -$0.95 | -$0.54 |
| Operating Income | -$34.64M | -$36.04M | -$88.92M | -$48.89M |
| Operating Income Ratio | -$0.39 | -$0.43 | -$1.09 | -$0.65 |
| Other Income/Expenses (Net) | $3.15M | $1.29M | $3.54M | $3.74M |
| Income Before Tax | -$31.50M | -$34.75M | -$85.38M | -$45.15M |
| Income Before Tax Ratio | -$0.36 | -$0.41 | -$1.05 | -$0.60 |
| Income Tax Expense | $97000.00 | -$96000.00 | $191000.00 | $345000.00 |
| Net Income | -$31.59M | -$34.66M | -$85.57M | -$45.49M |
| Net Income Ratio | -$0.36 | -$0.41 | -$1.05 | -$0.60 |
| EPS | -$0.53 | -$0.60 | -$1.47 | -$0.79 |
| Diluted EPS | -$0.53 | -$0.60 | -$1.47 | -$0.79 |
| Weighted Avg Shares Outstanding | $59.16M | $58.02M | $58.15M | $57.78M |
| Weighted Avg Shares Outstanding (Diluted) | $59.16M | $58.02M | $58.15M | $57.78M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan